AQST Overview
Upcoming Projects (AQST)
-
Don’t see a project related to the company you care about? Create your own!
Executed Projects (AQST)
-
Looking at the FDA Approval of the Neffy Spray (intranasal ephinephrine) from ARS Pharmaceuticals for anaphylactic shock
Tickers: SPRY, PFE, AQST
Executed On: Aug 15, 2024 at 04:45 PM EDT -
Discussing the Phase 3 study of Aquestive Therapeutics' Anaphylm (epinephrine) Sublingual Film for the treatment of severe life-threatening allergic reactions
Ticker: AQST
Executed On: Apr 09, 2024 at 04:00 PM EDT -
Discussing Anaphylm (AQST-109) and its ongoing EPIPHAST II trial comparing it to EpiPen and a generic epinephrine injection.
Ticker: AQST
Executed On: Feb 28, 2024 at 05:00 PM EST
Upcoming & Overdue Catalysts (AQST)
-
Don’t see a catalyst related to the company you care about? Create your own!
Occurred Catalysts (AQST)
-
Aquestive Therapeutics (AQST) Receives CRL from FDA for Libervant (diazepam) Buccal Film for Management of Seizure Clusters
Ticker: AQST
Occurred on: Sep 25, 2020 -
Aquestive Therapeutics (AQST) completes NDA submission for libervant buccal film
Ticker: AQST
Occurred on: Dec 02, 2019
Strategic Initiatives (AQST)
-
Don’t see a strategic initiative related to the company you care about? Create your own!
